A facilitated case-based discussion about the complexities of managing problematic polypharmacy and deprescribing in patients with cardiovascular disease.
This is a follow on from the polypharmacy webinar series (see Resources section below), which lays the foundations of some of the deprescribing tools available and features a generalist case study.
Why it’s important
The National Overprescribing review highlighted that 10% of medicines prescribed in primary care may be inappropriate and those taking 10 or more medicines are 300 times more likely to have a drug related hospital admission, highlighting the importance of deprescribing.
Structured medication reviews (SMRs) improve medication adherence, reduce unnecessary prescriptions, and optimise patient outcomes in cardiovascular care. By reviewing patient experience, symptoms and medication use, healthcare professionals can minimise risk of harm, limit side effects, and prevent poor health outcomes. This approach ensures that treatments remain appropriate and effective for better management of cardiovascular conditions and enhanced quality of life.
What will be covered
- Case-based discussion about undertaking an SMR in a patient with polypharmacy with a focus on cardiovascular disease.
- Insight into a person-centred approach to deprescribing and optimising medicines outcomes for patients with problematic polypharmacy.
- Discussion about the challenges that professionals commonly encounter in relation to deprescribing for patients with cardiovascular disease.
Speakers
A range of speakers from SPS and external organisations will facilitate this event.
Non-SPS speakers
Alison Warren
Consultant Pharmacist (Cardiology), University Hospitals Sussex and Sussex Integrated Care Board
SPS speakers
Learn more about our SPS team below.